Literature DB >> 15221923

The natural course of cutaneous melanoma.

Ulrike Leiter1, Friedegund Meier, Birgit Schittek, Claus Garbe.   

Abstract

The natural course of cutaneous melanoma (CM) is determined by its metastatic spread and depends on tumor thickness, ulceration, gender, localization, and the histologic subtype of the primary tumor. CM metastasis develops via three main metastatic pathways and occurs as satellite or in-transit metastasis, as regional lymph node metastasis or as distant metastasis at the time of primary recurrence. About 50% of all CM patients with tumor progression firstly develop regional lymph node metastases. In the other 50% the first metastases are satellite or in-transit metastases (about 20%), or immediately distant metastases (about 30%). Development of distant metastasis appears to be an early event in metastatic spread and may in the majority of cases originate from the primary tumor, only few cases may develop secondarily to locoregional metastasis. Reporting of organ involvement in distant metastasis greatly differs between the results of imaging techniques and autopsy results in respect to the metastatic patterns detected, pointing out that there is a need of improved imaging systems. Proliferation, neovascularization, lymphangiogenesis, invasion, circulation, and embolism are important steps in the pathogenesis of CM metastasis, with tumor vascularity as an important independent significant prognostic factor. The expression of chemokine receptors in cancer cells associated with the expression of the respective chemokine receptor ligands in the target sites of the metastasis is an interesting observation which may stimulate the development of new therapeutic strategies. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15221923     DOI: 10.1002/jso.20079

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  68 in total

1.  A simple engineered platform reveals different modes of tumor-microenvironmental cell interaction.

Authors:  Chentian Zhang; Elizabeth M Shenk; Laura C Blaha; Byungwoo Ryu; Rhoda M Alani; Mario Cabodi; Joyce Y Wong
Journal:  Biofabrication       Date:  2015-12-30       Impact factor: 9.954

2.  Cell cycle analysis can differentiate thin melanomas from dysplastic nevi and reveals accelerated replication in thick melanomas.

Authors:  Gergo Kiszner; Barnabas Wichmann; Istvan B Nemeth; Erika Varga; Nora Meggyeshazi; Ivett Teleki; Peter Balla; Mate E Maros; Karoly Penksza; Tibor Krenacs
Journal:  Virchows Arch       Date:  2014-03-30       Impact factor: 4.064

Review 3.  Clinical and biological aspects of sentinel node biopsy in malignant melanoma--an update.

Authors:  Isabel Callejo Peixoto; José Meneses e Sousa
Journal:  Clin Transl Oncol       Date:  2005-05       Impact factor: 3.405

4.  Malignant melanoma of the ciliary body presenting as extraocular metastasis in the temporalis muscle.

Authors:  Henna Anu-Liisa Oittinen; Michael O'Shaughnessy; Anthony B Cullinane; Catherine Keohane
Journal:  J Clin Pathol       Date:  2007-06-01       Impact factor: 3.411

Review 5.  Precision Medicine and PET/Computed Tomography in Melanoma.

Authors:  Esther Mena; Yasemin Sanli; Charles Marcus; Rathan M Subramaniam
Journal:  PET Clin       Date:  2017-07-14

Review 6.  Long-term follow-up for melanoma patients: is there any evidence of a benefit?

Authors:  Natasha M Rueth; Kate D Cromwell; Janice N Cormier
Journal:  Surg Oncol Clin N Am       Date:  2015-01-24       Impact factor: 3.495

7.  Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy.

Authors:  R Taylor Ripley; Jeremy L Davis; Jacob A Klapper; Aarti Mathur; Udai Kammula; Richard E Royal; James C Yang; Richard M Sherry; Marybeth S Hughes; Steven K Libutti; Donald E White; Seth M Steinberg; Mark E Dudley; Steven A Rosenberg; Itzhak Avital
Journal:  Ann Surg Oncol       Date:  2009-09-24       Impact factor: 5.344

8.  Genetics of uveal melanoma and cutaneous melanoma: two of a kind?

Authors:  Thomas van den Bosch; Emine Kilic; Dion Paridaens; Annelies de Klein
Journal:  Dermatol Res Pract       Date:  2010-06-06

9.  Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients.

Authors:  Massimo Mascolo; Maria Luisa Vecchione; Gennaro Ilardi; Massimiliano Scalvenzi; Guido Molea; Maria Di Benedetto; Loredana Nugnes; Maria Siano; Gaetano De Rosa; Stefania Staibano
Journal:  BMC Cancer       Date:  2010-02-24       Impact factor: 4.430

10.  A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis.

Authors:  J S Blackburn; I Liu; C I Coon; C E Brinckerhoff
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.